查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587818

血液篩檢市場規模、佔有率、趨勢分析報告：按技術、按產品、按地區、細分市場預測，2025-2030 年

Blood Screening Market Size, Share & Trends Analysis Report By Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), By Product (Reagent, Instrument), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

血液篩檢市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球血液篩檢市場規模預計將達到66.2億美元，2025年至2030年複合年成長率為11.9%。

該市場的成長得益於捐贈者篩檢的增加和市場參與企業不斷進步的技術。由於捐血的增加、對輸血感染疾病的認知的提高以及行業技術的發展，對血液篩檢測試的需求持續增加。此外，各國政府要求對所有捐血的血液進行多種病毒檢測。

需要對所有捐血的血液進行徹底篩檢，以確保接受者獲得最安全的血液製品。截至 2015 年，此類檢測包括篩檢紅血球抗體和感染疾病病原體：HIV-1、HIV-2、肝炎病毒、西尼羅河病毒 (WNV)、人類 T 淋巴細胞病毒 (HTLV)、T. Cruzi，T. pallidum（梅毒）。捐血的一個條件是所有這些測試結果均為陰性。

技術的發展正在提高測試的靈敏度和效率。例如，2016 年，美國FDA核准了Hologic, Inc. 和 Grifols 的 Procleix茲卡病毒檢測方法，用於篩檢捐血的血液。此外，美國FDA 於 2013 年核准了下一代定序 (NGS) 技術。該技術比傳統 DNA 分析方法更便宜、更快速。

血液篩檢市場報告亮點

  • 核酸增幅檢查（NAT）佔據市場主導地位，2024 年佔最大收益佔有率，達 41.2%。這是因為HIV、肝炎等感染疾病的盛行率不斷增加，需要NAAT提供的準確、快速的檢測方法。
  • 次世代定序(NGS) 預計在預測期內複合年成長率為 16.5%。這項技術顯著降低了定序成本，同時提高了準確性，徹底改變了基因組分析。
  • 試劑引領市場，2024 年佔最大銷售佔有率，達 73.4%。試劑是診斷測試的重要組成部分，提供引發特定反應以獲得準確結果所需的化學、生物和免疫物質。
  • 由於技術進步和對有效診斷解決方案的需求不斷增加，預計設備在預測期內將以 10.8% 的最快複合年成長率成長。
  • 北美血液篩檢市場在全球市場佔據主導地位，2024年收益佔有率最大，為38.4%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章血液篩檢市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章血液篩檢市場：技術業務分析

  • 2024年及2030年技術市場佔有率
  • 技術細分儀表板
  • 2018-2030 年按技術分類的市場規模、預測與趨勢分析
  • 核酸增幅檢查（NAT）
  • ELISA
  • 化學冷光免疫檢測（CLIA & EIA）
  • 次世代定序（NGS）
  • 蛋白質印跡 (WB)

第5章血液篩檢市場：產品業務分析

  • 2024年及2030年產品市場佔有率
  • 產品細分儀表板
  • 2018-2030 年按產品分類的市場規模、預測與趨勢分析
  • 試劑
  • 裝置

第6章血液篩檢市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭狀況

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介
    • Abbott
    • Danaher Corporation（Beckman Coulter）
    • Becton Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Hoffman-La Roche Ltd.
    • Grifols, SA
    • Ortho-Clinical Diagnostics, Inc.
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific, Inc.
    • SOFINA sa（Biomerieux）
Product Code: GVR-1-68038-215-0

Blood Screening Market Growth & Trends:

The global blood screening market size is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for blood screening tests is increasing continuously due to increasing donation, rising awareness about transfusion-transmitted diseases, and technological developments in the industry. Furthermore, governments of various countries are in process to mandates testing all donated blood for several viruses.

Thorough screening is necessary for all donated blood to ensure that recipients receive the safest products. As of 2015, such testing consists of screening for red cell antibodies, and the infectious diseases agents: HIV-1, HIV-2, hepatitis virus, West Nile Virus (WNV), Human T-Lymphotropic Virus (HTLV) T. Cruzi, and T. pallidum (syphilis). The result of all these assays must be negative for blood donation.

Technological developments increase the sensitivity and efficiency of the tests. For instance, in 2016, the U.S. FDA approved the Procleix Zika virus assay from Hologic, Inc. and Grifols to screen donated blood. Furthermore, the U.S. FDA approved next-generation sequencing (NGS) technology in 2013. The technology is cheaper and faster than previous DNA analysis methods.

Blood Screening Market Report Highlights:

  • Nucleic acid amplification tests (NAT) dominated the market and accounted for the largest revenue share of 41.2% in 2024 attributed to the increasing prevalence of infectious diseases, such as HIV and hepatitis, necessitating accurate and rapid testing methods that NAATs provide.
  • Next Generation Sequencing (NGS) is expected to grow at a CAGR of 16.5% over the forecast period. The technology has revolutionized genomic analysis by significantly reducing sequencing costs while improving accuracy.
  • Reagents led the market and accounted for the largest revenue share of 73.4% in 2024. Reagents are essential components in diagnostic tests, providing the necessary chemical, biological, or immunological substances to elicit specific reactions for accurate results.
  • Instruments are expected to grow at the fastest CAGR of 10.8% over the forecast period, owing to technological advancements and increasing demand for effective diagnostic solutions.
  • North America blood screening market dominated the global market and accounted for the largest revenue share of 38.4% in 2024 attributed to advanced healthcare infrastructure and a strong emphasis on patient safety.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Blood Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Blood Screening Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. Nucleic Acid Amplification Test (NAT)
    • 4.4.1. Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
  • 4.5. ELISA
    • 4.5.1. ELISA Market, 2018 - 2030 (USD Million)
  • 4.6. Chemiluminescence Immunoassay (CLIA & EIA )
    • 4.6.1. Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
  • 4.7. Next Generation Sequencing (NGS)
    • 4.7.1. Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
  • 4.8. Western Blotting (WB)
    • 4.8.1. Western Blotting (WB) Market, 2018 - 2030 (USD Million)

Chapter 5. Blood Screening Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Reagent
    • 5.4.1. Reagent Market, 2018 - 2030 (USD Million)
  • 5.5. Instrument
    • 5.5.1. Instrument Market, 2018 - 2030 (USD Million)

Chapter 6. Blood Screening Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamic
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamic
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamic
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamic
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamic
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamic
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamic
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamic
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamic
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamic
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamic
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamic
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamic
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamic
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamic
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamic
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamic
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamic
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamic
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamic
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamic
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamic
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamic
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Blood Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Abbott
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Danaher Corporation (Beckman Coulter)
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Becton Dickinson and Company
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Bio-Rad Laboratories, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Hoffman-La Roche Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Grifols, S.A.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Ortho-Clinical Diagnostics, Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Siemens Healthcare GmbH
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Thermo Fisher Scientific, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. SOFINA s.a (Biomerieux)
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Blood Screening Market, by Region, 2018-2030 (USD Million)
  • Table 4. Global Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5. Global Blood Screening Market, by Product, 2018-2030 (USD Million)
  • Table 6. North America Blood Screening Market, by Country, 2018-2030 (USD Million)
  • Table 7. North America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 8. North America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. U.S. Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10. U.S. Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 11. Canada Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12. Canada Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 13. Mexico Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14. Mexico Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. Europe Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 17. Europe Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. UK Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19. UK Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 20. Germany Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 21. Germany Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. France Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23. France Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 24. Italy Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25. Italy Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 26. Spain Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27. Spain Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. Norway Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29. Norway Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 30. Denmark Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31. Denmark Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 32. Sweden Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33. Sweden Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 37. Japan Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38. Japan Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 39. China Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40. China Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 41. India Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 42. India Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Australia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44. Australia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 45. South Korea Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 46. South Korea Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Thailand Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48. Thailand Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 49. Latin America Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51. Latin America Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 52. Brazil Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53. Brazil Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Argentina Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 55. Argentina Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Blood Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 59. South Africa Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60. South Africa Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 63. UAE Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64. UAE Blood Screening Market, by Product, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Blood Screening Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Blood Screening Market, by Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Blood Screening Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot

Fig. 9 Product, and Technology Outlook (USD Million)

  • Fig. 10 Product, and Technology Outlook
  • Fig. 11 Competitive Landscape
  • Fig. 12 Blood Screening Market Dynamics
  • Fig. 13 Blood Screening Market: Porter's Five Forces Analysis
  • Fig. 14 Blood Screening Market: PESTLE Analysis
  • Fig. 15 Blood Screening Market: Technology Segment Dashboard
  • Fig. 16 Blood Screening Market: Technology Market Share Analysis, 2024 & 2030
  • Fig. 17 Nucleic Acid Amplification Test (NAT) Market, 2018 - 2030 (USD Million)
  • Fig. 18 ELISA Market, 2018 - 2030 (USD Million)
  • Fig. 19 Chemiluminescence Immunoassay (CLIA & EIA ) Market, 2018 - 2030 (USD Million)
  • Fig. 20 Next Generation Sequencing (NGS) Market, 2018 - 2030 (USD Million)
  • Fig. 21 Western Blotting (WB) Market, 2018 - 2030 (USD Million)
  • Fig. 22 Blood Screening Market: Product Segment Dashboard
  • Fig. 23 Blood Screening Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 24 Reagent Market, 2018 - 2030 (USD Million)
  • Fig. 25 Instrument Market, 2018 - 2030 (USD Million)
  • Fig. 26 Blood Screening Market Revenue, by Region
  • Fig. 27 Regional marketplace: Key Takeaways
  • Fig. 28 Regional marketplace: Key Takeaways
  • Fig. 29 North America Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Country Dynamics
  • Fig. 31 U.S. Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Country Dynamics
  • Fig. 33 Canada Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Country Dynamics
  • Fig. 35 Mexico Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 37 UK Country Dynamics
  • Fig. 38 UK Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Country Dynamics
  • Fig. 40 Germany Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 41 France Country Dynamics
  • Fig. 42 France Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Country Dynamics
  • Fig. 44 Italy Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Country Dynamics
  • Fig. 46 Spain Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Country Dynamics
  • Fig. 48 Norway Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Country Dynamics
  • Fig. 50 Sweden Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark Country Dynamics
  • Fig. 52 Denmark Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Country Dynamics
  • Fig. 55 Japan Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 56 China Country Dynamics
  • Fig. 57 China Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 58 India Country Dynamics
  • Fig. 59 India Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Country Dynamics
  • Fig. 61 Australia Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea Country Dynamics
  • Fig. 63 South Korea Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Country Dynamics
  • Fig. 65 Thailand Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Country Dynamics
  • Fig. 68 Brazil Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina Country Dynamics
  • Fig. 70 Argentina Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa Country Dynamics
  • Fig. 73 South Africa Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia Country Dynamics
  • Fig. 75 Saudi Arabia Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE Country Dynamics
  • Fig. 77 UAE Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait Key Country Dynamics
  • Fig. 79 Kuwait Blood Screening Market, 2018 - 2030 (USD Million)
  • Fig. 80 Company Categorization
  • Fig. 81 Company Market Position Analysis
  • Fig. 82 Strategic Framework